Hooman Kamel, M.D., M.S.
< Back to Search Results

Hooman Kamel, M.D., M.S.


Profile Photo of Hooman Kamel, M.D., M.S.
Not Accepting New Patients
Gender: Male
Language: English


Specialties and Expertise


  • Critical Care Neurology
  • Vascular Neurology


  • Atrial Fibrillation
  • Critical Care
  • Stroke


Dr. Kamel is the Vice Chair for Research and Chief of Neurocritical Care in the Department of Neurology at Weill Cornell Medicine. He is also the Director of the Clinical and Translational Neuroscience Unit in the Feil Family Brain and Mind Research Institute and the Department of Neurology at Weill Cornell Medicine. His research focuses on the relationship between cardiac disease and stroke. He has published several studies showing that atrial cardiopathy may be a previously unrecognized risk factor for stroke. He is a principal investigator and protocol lead for the NIH-funded ARCADIA trial, which is testing antithrombotic strategies in patients with stroke and atrial cardiopathy. He is also a principal investigator of the NIH-funded ASPIRE trial, which is testing antithrombotic strategies in patients with atrial fibrillation and intracerebral hemorrhage. He has published over 300 scientific publications, including in leading journals such as NEJM and JAMA.

Dr. Kamel attended college at Harvard and medical school at Columbia, then trained as a neurology resident and neurocritical care fellow at the University of California, San Francisco before joining Weill Cornell Medicine in 2011. He has a masters degree in data science from the Columbia University Data Science Institute and is spearheading efforts to establish neurocritical care research registries using existing electronic medical records. Dr. Kamel has led multiple studies using novel “big data” approaches on a variety of topics including cardiovascular complications of pregnancy, liver disease, and sepsis.

Dr. Kamel is a member of the international AF-SCREEN collaboration and the American Neurological Association Scientific Program Advisory Committee. He serves as the Deputy Editor of JAMA Neurology and an editorial board member of Stroke. His academic contributions have been recognized by the Michael S. Pessin Stroke Leadership Prize from the American Academy of Neurology and the Robert G. Siekert New Investigator Award in Stroke and the Joseph A. Vita Award from the American Heart Association.


Honors and Awards

Honors and Awards

2000                Undergraduate Leadership Scroll, Harvard

2005                Helen M. Sciarra Prize for Outstanding Performance in Neurology, Columbia

2009                Outstanding Research Award, UCSF Clinical and Translational Science Institute

2010                Innovation Fund Award, UCSF Academy of Medical Educators

2011                Loan Repayment Program Award, National Institutes of Health

2012                Cornell Neurology Residents’ Annual Award for Faculty Teaching

2013                American Heart Association Scientist Development Grant 

2013                NIH/NINDS K23 Career Development Award

2013                Weill Cornell Healthcare Leadership Fellow

2014                Presidential Citation, Neurocritical Care Society

2014                Michael S. Pessin Stroke Leadership Prize, American Academy of Neurology

2016                Robert G. Siekert New Investigator Award, American Heart Association

2020                Joseph A. Vita Award, American Heart Association


Board Certifications

  • American Board of Psychiatry & Neurology
  • American Board of Psychiatry & Neurology
  • United Council for Neurological Subspecialties (Neurocritical Care)

Clinical and Academic Positions

  • Associate Professor of Neuroscience - Weill Cornell Medical College, Cornell University
  • Associate Professor of Neurology - Weill Cornell Medical College, Cornell University
  • Associate Attending Neurologist - NewYork-Presbyterian Hospital

Education and Training

  • M.S., Columbia University, 2020
  • M.D., Columbia University College of Physicians and Surgeons, 2005
  • B.A., Harvard College, 2000


Insurance Plans Accepted

The following represents most of the managed care plans accepted by this doctor. If your insurance carrier does not appear here please contact the doctor’s office as they may have individual contracts not included on this site.

* indicates this doctor is no longer accepting new patients with this insurance plan.

  • AETNA - Medicare
  • Aetna Weill Cornell Employee Managed Care Plan
  • Aetna Weill Cornell Employee PPO Plan
  • Aetna-NYP - EPO/POS
  • Affinity Access
  • Affinity Health Plan
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield - Blue Access
  • Empire Blue Cross/Blue Shield - Blue Connection
  • Empire Blue Cross/Blue Shield - EPO
  • Empire Blue Cross/Blue Shield - HMO
  • Empire Blue Cross/Blue Shield - Mediblue (Senior)
  • Empire Blue Cross/Blue Shield - PPO
  • Empire Blue Cross/Blue Shield HealthPlus
  • Empire Blue Cross/Blue Shield HealthPlus - CHP
  • Fidelis Care
  • GHI - CBP
  • Health First
  • Health Insurance Plan of NY (HIP) - Medicaid
  • Health Insurance Plan of NY (HIP) - Medicare
  • Health Insurance Plan of NY (HIP)
  • Medicaid
  • Medicare
  • Oxford Health Plans - Medicare Advantage
  • Oxford Health Plans - Metro/Core/Charter
  • Oxford Health Plans - Liberty
  • Oxford Health Plans - Freedom
  • Rockefeller University - Trustmark
  • United Empire
  • United Healthcare
  • United Healthcare - Community Plan
  • United Healthcare - Medicare
  • United Healthcare Compass
  • VNSNY CHOICE - Medicare
  • WorldWide Medical

Locations and Appointments

External Relationships

External Relationships

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Other Interest:
American Medical Association; AstraZeneca Pharmaceuticals LP; Janssen Research & Development, LLC; Novo Nordisk Pharmaceuticals, Inc.
TETMedical, Inc.